Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Human IgA binds a diverse array of commensal bacteria.

Sterlin D, Fadlallah J, Adams O, Fieschi C, Parizot C, Dorgham K, Rajkumar A, Autaa G, El-Kafsi H, Charuel JL, Juste C, Jönsson F, Candela T, Wardemann H, Aubry A, Capito C, Brisson H, Tresallet C, Cummings RD, Larsen M, Yssel H, von Gunten S, Gorochov G.

J Exp Med. 2020 Mar 2;217(3). pii: e20181635. doi: 10.1084/jem.20181635.

PMID:
31891367
2.

The Future of Pharmacology: Towards More Personalized Pharmacotherapy and Reverse Translational Research.

von Gunten S.

Pharmacology. 2020;105(1-2):1-2. doi: 10.1159/000505216. Epub 2019 Dec 10. No abstract available.

3.

Allergy and Atopic Diseases: An Update on Experimental Evidence.

Verschoor D, von Gunten S.

Int Arch Allergy Immunol. 2019;180(4):235-243. doi: 10.1159/000504439. Epub 2019 Nov 6. Review.

4.

The architecture of the IgG anti-carbohydrate repertoire in primary antibody deficiencies.

Jandus P, Boligan KF, Smith DF, de Graauw E, Grimbacher B, Jandus C, Abdelhafez MM, Despont A, Bovin N, Simon D, Rieben R, Simon HU, Cummings RD, von Gunten S.

Blood. 2019 Nov 28;134(22):1941-1950. doi: 10.1182/blood.2019001705.

5.

Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells.

Dorvignit D, Boligan KF, Relova-Hernández E, Clavell M, López A, Labrada M, Simon HU, López-Requena A, Mesa C, von Gunten S.

Sci Rep. 2019 Jul 9;9(1):9921. doi: 10.1038/s41598-019-46148-1.

6.

Differential Recognition of Diet-Derived Neu5Gc-Neoantigens on Glycan Microarrays by Carbohydrate-Specific Pooled Human IgG and IgA Antibodies.

Leviatan Ben-Arye S, Schneider C, Yu H, Bashir S, Chen X, von Gunten S, Padler-Karavani V.

Bioconjug Chem. 2019 May 15;30(5):1565-1574. doi: 10.1021/acs.bioconjchem.9b00273. Epub 2019 Apr 24.

PMID:
30994337
7.

Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment.

Haas Q, Boligan KF, Jandus C, Schneider C, Simillion C, Stanczak MA, Haubitz M, Seyed Jafari SM, Zippelius A, Baerlocher GM, Läubli H, Hunger RE, Romero P, Simon HU, von Gunten S.

Cancer Immunol Res. 2019 May;7(5):707-718. doi: 10.1158/2326-6066.CIR-18-0505. Epub 2019 Apr 15.

PMID:
30988027
8.

Granulocyte death mediated by specific antibodies in intravenous immunoglobulin (IVIG).

Graeter S, Simon HU, von Gunten S.

Pharmacol Res. 2019 Feb 6:104168. doi: 10.1016/j.phrs.2019.02.007. [Epub ahead of print] Review.

PMID:
30738127
9.

Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo.

Basaco T, Pektor S, Bermudez JM, Meneses N, Heller M, Galván JA, Boligán KF, Schürch S, von Gunten S, Türler A, Miederer M.

Pharmaceuticals (Basel). 2018 Nov 28;11(4). pii: E132. doi: 10.3390/ph11040132.

10.

Recent Advances in Experimental Allergy.

Adams OJ, von Gunten S.

Int Arch Allergy Immunol. 2018;177(4):281-289. doi: 10.1159/000494440. Epub 2018 Nov 13. Review.

11.

Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells.

Stanczak MA, Siddiqui SS, Trefny MP, Thommen DS, Boligan KF, von Gunten S, Tzankov A, Tietze L, Lardinois D, Heinzelmann-Schwarz V, von Bergwelt-Baildon M, Zhang W, Lenz HJ, Han Y, Amos CI, Syedbasha M, Egli A, Stenner F, Speiser DE, Varki A, Zippelius A, Läubli H.

J Clin Invest. 2018 Nov 1;128(11):4912-4923. doi: 10.1172/JCI120612. Epub 2018 Sep 24.

12.

A Cartography of Siglecs and Sialyltransferases in Gynecologic Malignancies: Is There a Road Towards a Sweet Future?

Haas Q, Simillion C, von Gunten S.

Front Oncol. 2018 Mar 13;8:68. doi: 10.3389/fonc.2018.00068. eCollection 2018.

13.

Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer.

Adams OJ, Stanczak MA, von Gunten S, Läubli H.

Glycobiology. 2018 Sep 1;28(9):640-647. doi: 10.1093/glycob/cwx108. Review.

PMID:
29309569
14.

Isolation of Antibodies from Human Plasma, Saliva, Breast Milk, and Gastrointestinal Fluid.

Schneider C, Illi M, Lötscher M, Wehrli M, von Gunten S.

Methods Mol Biol. 2017;1643:23-31. doi: 10.1007/978-1-4939-7180-0_3.

PMID:
28667527
15.

IVIG regulates the survival of human but not mouse neutrophils.

Schneider C, Wicki S, Graeter S, Timcheva TM, Keller CW, Quast I, Leontyev D, Djoumerska-Alexieva IK, Käsermann F, Jakob SM, Dimitrova PA, Branch DR, Cummings RD, Lünemann JD, Kaufmann T, Simon HU, von Gunten S.

Sci Rep. 2017 May 2;7(1):1296. doi: 10.1038/s41598-017-01404-0.

16.

The Potential Use of Pharmacological Agents to Modulate Orthodontic Tooth Movement (OTM).

Kouskoura T, Katsaros C, von Gunten S.

Front Physiol. 2017 Feb 8;8:67. doi: 10.3389/fphys.2017.00067. eCollection 2017. Review.

17.

Innate lymphoid cells in asthma: cannabinoids on the balance.

Boligan KF, von Gunten S.

Allergy. 2017 Jun;72(6):839-841. doi: 10.1111/all.13145. No abstract available.

PMID:
28226397
18.

Antibody repertoire profiling with mimotope arrays.

Pashova S, Schneider C, von Gunten S, Pashov A.

Hum Vaccin Immunother. 2017 Feb;13(2):314-322. doi: 10.1080/21645515.2017.1264786. Epub 2016 Dec 8.

19.

Synchrotron microbeam irradiation induces neutrophil infiltration, thrombocyte attachment and selective vascular damage in vivo.

Brönnimann D, Bouchet A, Schneider C, Potez M, Serduc R, Bräuer-Krisch E, Graber W, von Gunten S, Laissue JA, Djonov V.

Sci Rep. 2016 Sep 19;6:33601. doi: 10.1038/srep33601.

20.

Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.

Späth PJ, Schneider C, von Gunten S.

Arch Immunol Ther Exp (Warsz). 2017 Jun;65(3):215-231. doi: 10.1007/s00005-016-0422-x. Epub 2016 Sep 16. Review.

PMID:
27638480

Supplemental Content

Loading ...
Support Center